New nanopore-based tool enables single molecule disease detection

UC Riverside scientists have developed a nanopore-based tool that could help diagnose illnesses much faster and with greater precision than current tests allow, by capturing signals from individual molecules.

PAION AG CHANGES FROM PRIME STANDARD TO GENERAL STANDARD – Biotech Investments

EQS-News: PAION AG / Key word(s): Miscellaneous PAION AG CHANGES FROM PRIME STANDARD TO GENERAL STANDARD 22.11.2023 / 16:05 CET/CEST The issuer is solely responsible

November 23, 2023

US FDA grants approval for Pfizer’s RSV vaccine

The FDA approved Pfizer’s Abrysvo based on the findings from the Phase III MATISSE clinical trial. Credit: Pfizer. The US Food and Drug Administration (FDA)

August 22, 2023

BMS expands Krazati’s FDA label to include colorectal cancer

BMS added Krazati to its portfolio when it acquired Mirati Therapeutics for $5.8bn. Credit: Katherine Welles/Shutterstock. The US Food and Drug Administration (FDA) has approved

June 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.